Results 21 to 30 of about 795,358 (192)

Treatment of generalized pustular psoriasis with Spesolimab: a case report and literature review

open access: yesPifu-xingbing zhenliaoxue zazhi
Objective To evaluate the efficacy and safety of Spesolimab in the treatment of generalized pustular psoriasis(GPP). Methods A 30 years old female with GPP was intravenously given 900 mg of Spesolimab once.
Xiaoqian LIANG   +3 more
doaj   +2 more sources

Update on Generalized Pustular Psoriasis

open access: yesActa Médica Portuguesa
Generalized pustular psoriasis (GPP) is a rare but severe inflammatory skin disease characterized by the eruption of widespread sterile pustules, often accompanied by systemic inflammation.
Tiago Torres   +9 more
doaj   +3 more sources

Ustekinumab in the Treatment of Generalized Pustular Psoriasis in a Pregnant Patient [PDF]

open access: yesClinical, Cosmetic and Investigational Dermatology
Hao Wu, Yan Na Shen, Zhongxiao Wu, Feng Mao, You Gang Ren, Li Zhang Department of Dermatology, Ningbo No 6 Hospital, Ningbo, 315040, People’s Republic of ChinaCorrespondence: Li Zhang, Email lishay1022@hotmail.comAbstract: Although the use of biologics ...
Wu H   +5 more
doaj   +1 more source

Diagnosis of Generalized Pustular Psoriasis [PDF]

open access: yesAmerican Journal of Clinical Dermatology, 2022
Generalized pustular psoriasis (GPP) is a severe rare skin disease characterized by widespread eruption of sterile superficial macroscopic pustules with or without systemic inflammation. Generalized pustular psoriasis flares may lead to life-threatening multiorgan complications, which highlights the need for rapid and accurate diagnosis.
Hideki Fujita   +2 more
openaire   +2 more sources

Generalized pustular psoriasis. [PDF]

open access: yesBMJ, 1969
A patient with plaque psoriasis is described as having a generalized pustular reaction evoked by the topical use of crude coal tar. This pustular response was reproduced in a circumscribed area by an open patch test. It is suggested that hypersensitivity in the psoriatic, when the skin is one of the target organs, may result in generalized pustulation ...
M, Ogawa   +2 more
  +7 more sources

Innate immune cells express IL-17A/F in acute generalized exanthematous pustulosis and generalized pustular psoriasis. [PDF]

open access: yes, 2014
Acute generalized exanthematous pustulosis (AGEP) and generalized pustular psoriasis (GPP) are rare pustular skin disorders with systemic involvement. IL-17A/F is a proinflammatory cytokine involved in various neutrophilic inflammatory disorders. Here we
Tang, M M   +6 more
core   +3 more sources

The histopathological spectrum of acute generalized exanthematous pustulosis (AGEP) and its differentiation from generalized pustular psoriasis [PDF]

open access: yes, 2010
Background: Acute generalized exanthematous pustulosis (AGEP) represents a severe, acute, pustular skin reaction that is most often induced by drugs. AGEP can be difficult to differentiate from generalized pustular psoriasis (GPP) both clinically and ...
Fidler, Vaclav   +11 more
core   +2 more sources

Generalized Pustular Psoriasis

open access: yesNew England Journal of Medicine
Generalized pustular psoriasis (GPP) is a rare and highly heterogeneous skin disease, characterized by flares of neutrophilic pustules and erythema. As a rare disease with few clinical studies and no standardized management approaches, there is a paucity of knowledge regarding GPP.
Saleh HM, Sathe NC.
europepmc   +7 more sources

Manifestation of palmoplantar pustulosis during or after infliximab therapy for plaque-type psoriasis : report on five cases [PDF]

open access: yes, 2008
Infliximab is a monoclonal antibody directed against TNF-alpha. It has been approved for use in rheumatoid arthritis, ankylosing spondylitis, inflammatory bowel disease, psoriatic arthritis and plaque-type psoriasis.
Krüger, Ullrich   +6 more
core   +1 more source

Annular pustular psoriasis: A heterogeneous subtype of generalized pustular psoriasis

open access: yesChinese Medical Journal
Xiaoyan Wu   +4 more
doaj   +3 more sources

Home - About - Disclaimer - Privacy